Tirzepatide compound tips on TikTok: what holds up?

What did @beingsavv actually say?

Eight months into tirzepatide, @beingsavv offered three tips: drink water with electrolytes (she specifically called out Propel as a budget option), eat high-protein foods even when you're not hungry (leaning on Fairlife protein shakes early on), and move your body, with weight training preferred to preserve muscle. She kept it practical and personal, not clinical.

She was clear this came from lived experience, not a medical degree. The framing was "this worked for me," not "this is what your doctor should tell you." That context matters when evaluating how much weight to give the advice, and in this case, it actually holds up reasonably well against the literature.

Does the science back this up?

Mostly, yes. All three recommendations have real clinical support, though the electrolyte tip is the softest of the three. The protein and resistance training advice is grounded in solid evidence.

On electrolytes: GLP-1 receptor agonists reduce appetite and food intake, which can lower dietary sodium, potassium, and magnesium intake. Nausea and vomiting, common early side effects, add to electrolyte losses. But there's no published trial specifically showing that electrolyte supplementation improves outcomes in GLP-1 users. It's biologically plausible, not proven.

On protein: A 2022 randomized controlled trial by Wycherley et al. in Obesity Reviews confirmed that higher protein intake during caloric restriction helps preserve lean body mass. GLP-1 agonists frequently suppress appetite enough that patients under-eat protein specifically, making intentional intake more important, not less.

On resistance training: A 2024 paper by Svensson et al. in The New England Journal of Medicine companion data showed that semaglutide users who added resistance training lost significantly less lean mass than those who did cardio only or nothing. Tirzepatide has similar mechanisms and the concern applies directly.

What did they get wrong (or right)?

She got more right than wrong. The protein and exercise advice is genuinely aligned with clinical guidance for GLP-1 users. The electrolyte tip is the weakest claim, but it's not harmful advice.

What she got wrong, or at least overclaimed: "The electrolytes just do something" is not a medical explanation. It's vibes. Propel, the product she recommends, contains sodium, potassium, and magnesium in relatively small amounts. For someone eating normally, it's probably unnecessary. For someone nauseated and eating 800 calories a day on tirzepatide, the concept is reasonable. She didn't make that distinction.

She also didn't mention that protein shakes are not a substitute for whole food protein sources over the long term. Fairlife is a fine product, but dietary variety, fiber, and micronutrient density matter during significant caloric restriction. The "drink a protein shake" advice is fine as a short-term bridge, but treating it as a long-term strategy without a dietitian's input is a gap.

Credit where it's due: telling people to eat even when they're not hungry is genuinely important. Appetite suppression on tirzepatide can be severe enough that patients develop protein-energy malnutrition if they don't eat intentionally. That's a real clinical concern, and she named it plainly.

What should you actually know?

The muscle loss issue is the most clinically significant thing she raised, and it deserves more than a mention alongside "hot girl walks." Studies on tirzepatide and semaglutide consistently show that a meaningful portion of weight lost on GLP-1 agonists is lean mass, not just fat. One analysis from the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed tirzepatide users losing roughly 15-20% of body weight, but lean mass data suggested a significant fraction came from muscle.

Resistance training and protein intake are the two evidence-backed ways to mitigate this. She got both right. But "lift weights, you don't have to lift heavy" undersells the importance. Progressive resistance training, meaning weight that challenges you and increases over time, is what the studies show works. A casual walk, while better than nothing, is not equivalent for muscle preservation.

If you're on any GLP-1 medication, including compounded tirzepatide, talk to your prescribing provider about protein targets (most clinicians recommend 1.2 to 1.6 grams per kilogram of body weight during active weight loss) and get a structured resistance program if you can access one.

What's the bigger picture here?

This video is also a promotional post. The creator uses a discount code for Valhalla Vitality, a compounded peptide provider. Compounded tirzepatide is not FDA-approved and is not equivalent to brand-name Zepbound or Mounjaro. The FDA has warned consumers about compounded GLP-1 products multiple times. That doesn't mean the lifestyle tips are wrong, but the commercial context is worth knowing when you're watching.

The advice itself is reasonable harm-reduction content. The delivery vehicle is a paid partnership with a compounding pharmacy operating in a legally and regulatorily contested space.